SCHEMBL20037513

SCHEMBL20037513

CNc1ccc(N2CCNC[C@H]2C(F)(F)F)cn1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 8/20 0.39
SLC6A2 P23975 2/20 0.39
SLC6A4 P31645 2/20 0.39
SLC6A3 Q01959 2/20 0.39
CHRNB4 P30926 5/20 0.36
CHRNA3 P32297 5/20 0.36
CHRNB2 P17787 4/20 0.36
CHRNA4 P43681 4/20 0.36
IRAK4 Q9NWZ3 1/20 0.35
CDK2 P24941 4/20 0.34
CCNE1 P24864 3/20 0.34
CCND1 P24385 2/20 0.33
CDK1 P06493 1/20 0.33
CCNB1 P14635 1/20 0.33
CCNA2 P20248 1/20 0.33
CCNA1 P78396 1/20 0.33
CDK6 Q00534 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18291197 0.83 CHRNB2 (0.45) SLC6A2SLC6A4SLC6A3CHRNB4CHRNA3
SCHEMBL18291205 0.83 CHRNB2 (0.45) SLC6A2SLC6A4SLC6A3CHRNB4CHRNA3
SCHEMBL18291200 0.83 CHRNB2 (0.45) SLC6A2SLC6A4SLC6A3CHRNB4CHRNA3
SCHEMBL20249486 0.81 CHRNB2 (0.36) SLC6A2SLC6A4SLC6A3CHRNB4CHRNA3
SCHEMBL20249452 0.81 CHRNB2 (0.36) SLC6A2SLC6A4SLC6A3CHRNB4CHRNA3
SCHEMBL20249484 0.81 CHRNB2 (0.36) SLC6A2SLC6A4SLC6A3CHRNB4CHRNA3
SCHEMBL20255220 0.81 CHRNB2 (0.38) SLC6A2SLC6A4SLC6A3CHRNB4CHRNA3
SCHEMBL18291328 0.81 CHRNB2 (0.45) CHRNB4CHRNA3CHRNB2CHRNA4IRAK4
SCHEMBL20255093 0.81 CHRNB2 (0.38) SLC6A2SLC6A4SLC6A3CHRNB4CHRNA3
SCHEMBL25738410 0.80 AR (0.41) IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3305785-A1 PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Teijin Pharma Limited (JP) 2018-04-11 EP disclosed